Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083730 · ClinicalTrials.gov registry record · NA
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03083730 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 6 participants.
The verdict
NCT03083730, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Atopic dermatitis (eczema) is a chronic inflammatory disease that causes significant morbidity and is now known to be associated with cardiovascular disease. Research such as this will add to the understanding of the skin as a contributor to systemic inflammation, and it is important to clarify whether skin-only treatment can alleviate systemic inflammation, and potentially influence cardiovascular risk factors.
Interventions
- OTHER Narrow band UVB treatment (NB-UVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2020-02-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03083730
The ClinicalTrials.gov registry entry for NCT03083730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Narrow band UVB treatment (NB-UVB) is the first listed.
NCT03083730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03083730 about?
NCT03083730 is a clinical study titled "Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis". Atopic dermatitis (eczema) is a chronic inflammatory disease that causes significant morbidity and is now known to be associated with cardiovascular disease. Research such as this will add to the understanding of the skin as a contributor to systemic inflammation, and it is important to clarify whet...
What is the current status of trial NCT03083730?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2017-07-19. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03083730?
The interventions under investigation include: Narrow band UVB treatment (NB-UVB) (OTHER).
Who is sponsoring clinical trial NCT03083730?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.